259 related articles for article (PubMed ID: 24067366)
21. Small-molecule agonists of mammalian Diaphanous-related (mDia) formins reveal an effective glioblastoma anti-invasion strategy.
Arden JD; Lavik KI; Rubinic KA; Chiaia N; Khuder SA; Howard MJ; Nestor-Kalinoski AL; Alberts AS; Eisenmann KM
Mol Biol Cell; 2015 Nov; 26(21):3704-18. PubMed ID: 26354425
[TBL] [Abstract][Full Text] [Related]
22. The mechanical and pharmacological regulation of glioblastoma cell migration in 3D matrices.
Kaphle P; Li Y; Yao L
J Cell Physiol; 2019 Apr; 234(4):3948-3960. PubMed ID: 30132879
[TBL] [Abstract][Full Text] [Related]
23. Curcumin suppresses growth and chemoresistance of human glioblastoma cells via AP-1 and NFkappaB transcription factors.
Dhandapani KM; Mahesh VB; Brann DW
J Neurochem; 2007 Jul; 102(2):522-38. PubMed ID: 17596214
[TBL] [Abstract][Full Text] [Related]
24. Identification of non-canonical NF-κB signaling as a critical mediator of Smac mimetic-stimulated migration and invasion of glioblastoma cells.
Tchoghandjian A; Jennewein C; Eckhardt I; Rajalingam K; Fulda S
Cell Death Dis; 2013 Mar; 4(3):e564. PubMed ID: 23538445
[TBL] [Abstract][Full Text] [Related]
25.
Gwon DH; Lee WY; Shin N; Kim SI; Jeong K; Lee WH; Kim DW; Hong J; Lee SY
Int J Mol Sci; 2020 Mar; 21(7):. PubMed ID: 32231148
[TBL] [Abstract][Full Text] [Related]
26. Using the molecular classification of glioblastoma to inform personalized treatment.
Olar A; Aldape KD
J Pathol; 2014 Jan; 232(2):165-77. PubMed ID: 24114756
[TBL] [Abstract][Full Text] [Related]
27. Targeting the AKT pathway in glioblastoma.
McDowell KA; Riggins GJ; Gallia GL
Curr Pharm Des; 2011; 17(23):2411-20. PubMed ID: 21827416
[TBL] [Abstract][Full Text] [Related]
28. Swelling-induced chloride current in glioblastoma proliferation, migration, and invasion.
Wong R; Chen W; Zhong X; Rutka JT; Feng ZP; Sun HS
J Cell Physiol; 2018 Jan; 233(1):363-370. PubMed ID: 28262948
[TBL] [Abstract][Full Text] [Related]
29. Reduction of Akt2 inhibits migration and invasion of glioma cells.
Zhang B; Gu F; She C; Guo H; Li W; Niu R; Fu L; Zhang N; Ma Y
Int J Cancer; 2009 Aug; 125(3):585-95. PubMed ID: 19330838
[TBL] [Abstract][Full Text] [Related]
30. IL-17A promotes cell migration and invasion of glioblastoma cells via activation of PI3K/AKT signalling pathway.
Zheng Q; Diao S; Wang Q; Zhu C; Sun X; Yin B; Zhang X; Meng X; Wang B
J Cell Mol Med; 2019 Jan; 23(1):357-369. PubMed ID: 30353649
[TBL] [Abstract][Full Text] [Related]
31. MiR-223/PAX6 Axis Regulates Glioblastoma Stem Cell Proliferation and the Chemo Resistance to TMZ via Regulating PI3K/Akt Pathway.
Huang BS; Luo QZ; Han Y; Huang D; Tang QP; Wu LX
J Cell Biochem; 2017 Oct; 118(10):3452-3461. PubMed ID: 28332226
[TBL] [Abstract][Full Text] [Related]
32. Tumoral RANKL activates astrocytes that promote glioma cell invasion through cytokine signaling.
Kim JK; Jin X; Sohn YW; Jin X; Jeon HY; Kim EJ; Ham SW; Jeon HM; Chang SY; Oh SY; Yin J; Kim SH; Park JB; Nakano I; Kim H
Cancer Lett; 2014 Oct; 353(2):194-200. PubMed ID: 25079688
[TBL] [Abstract][Full Text] [Related]
33. miR-423-5p contributes to a malignant phenotype and temozolomide chemoresistance in glioblastomas.
Li S; Zeng A; Hu Q; Yan W; Liu Y; You Y
Neuro Oncol; 2017 Jan; 19(1):55-65. PubMed ID: 27471108
[TBL] [Abstract][Full Text] [Related]
34. Downregulation of Akt and FAK phosphorylation reduces invasion of glioblastoma cells by impairment of MT1-MMP shuttling to lamellipodia and downregulates MMPs expression.
Kwiatkowska A; Kijewska M; Lipko M; Hibner U; Kaminska B
Biochim Biophys Acta; 2011 May; 1813(5):655-67. PubMed ID: 21276823
[TBL] [Abstract][Full Text] [Related]
35. Inhibition of TRPM7 by carvacrol suppresses glioblastoma cell proliferation, migration and invasion.
Chen WL; Barszczyk A; Turlova E; Deurloo M; Liu B; Yang BB; Rutka JT; Feng ZP; Sun HS
Oncotarget; 2015 Jun; 6(18):16321-40. PubMed ID: 25965832
[TBL] [Abstract][Full Text] [Related]
36. CBF1 is clinically prognostic and serves as a target to block cellular invasion and chemoresistance of EMT-like glioblastoma cells.
Maciaczyk D; Picard D; Zhao L; Koch K; Herrera-Rios D; Li G; Marquardt V; Pauck D; Hoerbelt T; Zhang W; Ouwens DM; Remke M; Jiang T; Steiger HJ; Maciaczyk J; Kahlert UD
Br J Cancer; 2017 Jun; 117(1):102-112. PubMed ID: 28571041
[TBL] [Abstract][Full Text] [Related]
37. Suppression of the invasive potential of Glioblastoma cells by mTOR inhibitors involves modulation of NFκB and PKC-α signaling.
Chandrika G; Natesh K; Ranade D; Chugh A; Shastry P
Sci Rep; 2016 Mar; 6():22455. PubMed ID: 26940200
[TBL] [Abstract][Full Text] [Related]
38. C-type lectin domain family 5, member A (CLEC5A, MDL-1) promotes brain glioblastoma tumorigenesis by regulating PI3K/Akt signalling.
Fan HW; Ni Q; Fan YN; Ma ZX; Li YB
Cell Prolif; 2019 May; 52(3):e12584. PubMed ID: 30834619
[TBL] [Abstract][Full Text] [Related]
39. NADPH Oxidases NOXs and DUOXs as putative targets for cancer therapy.
Weyemi U; Redon CE; Parekh PR; Dupuy C; Bonner WM
Anticancer Agents Med Chem; 2013 Mar; 13(3):502-14. PubMed ID: 22931418
[TBL] [Abstract][Full Text] [Related]
40. miR128-1 inhibits the growth of glioblastoma multiforme and glioma stem-like cells via targeting BMI1 and E2F3.
Shan ZN; Tian R; Zhang M; Gui ZH; Wu J; Ding M; Zhou XF; He J
Oncotarget; 2016 Nov; 7(48):78813-78826. PubMed ID: 27705931
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
